{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "go:GO:0007155",
      "entity_text" : "adhesion",
      "entity_type" : "bioprocess"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ02980",
      "entity_text" : "ocriplasmin",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "The role for ocriplasmin to enhance release of vitreomacular adhesion in cases besides VMA, for example DME, AMD, and pediatric eyes before vitrectomy, has been studied, but preliminary results are not as positive as for VMA, and should still be considered experimental.",
  "reading_complete" : "2020-08-05T22:17:19Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-05T22:15:28Z",
  "trigger" : "enhance",
  "evidence" : [ "ocriplasmin to enhance release of vitreomacular adhesion" ],
  "pmc_id" : "3968080",
  "score" : 0
}